ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. On November 24, 2008, ImClone Sys...
Use this information to figure out if this company is an ideal customer for you.
(317) 276-xxxx
50 Imclone Dr
Branchburg, 08876
501 - 1,000 Employees
$1B+
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's CEO is Mark Glick
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's CTO is Stephen Kuropchak
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's HQ is located at 50 Imclone Dr, Branchburg
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's phone number is (317) 276-xxxx
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's official website is imclone.com
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's revenue is $1B+
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company has 501 - 1,000 employees
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company is in the industry of: Biotechnology